Mature B-Cell Neoplasm — Trials

Mature B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,664 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 201–250 of 1,250 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02874742	Study Comparing Daratumumab, Lenalidomide, Bortezomib, and Dexamethasone (D-RVd) Versus Lenalidomide, Bortezomib, and Dexamethasone (RVd) in Subjects With Newly Diagnosed Multiple Myeloma	completed	Phase 2	224	Janssen Research & Development, LLCINDUSTRY	1	Feb 4, 2025	clinicaltrials
NCT03357952	A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma	completed	Phase 2 / Phase 3	10	Janssen Research & Development, LLC